( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

43 publications found

Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Cesar Libanati - author of 7 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial[1]Akimitsu Miyauchi, [2]Etsuro Hamaya, [3]Wenjing Yang, [4]Kiyoshi Nishi, [5]Cesar Libanati, [6]Cae Tolman, [7]Junichiro Shimauchi [Full author list]Journal of Bone and Mineral Metabolism [missing]DOI: 10.1007/S00774-020-01147-5 [ORCID]
PubMed: 33057807 [ORCID]
2020-10-15Cesar Libanati (Q91116106; 7 items)
Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial[1]Junichi Takada, [2]Rajani Dinavahi, [3]Akimitsu Miyauchi, [4]Etsuro Hamaya, [5]Toshiyasu Hirama, [6]Cesar Libanati, [7]Yoichi Nakamura, [8]Cassandra E Milmont, [9]Andreas Grauer [Full author list]Journal of Bone and Mineral Metabolism [missing]DOI: 10.1007/S00774-020-01099-W [ORCID]
PubMed: 32198616 [ORCID]
2020-03-20Cesar Libanati (Q91116106; 7 items)
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial[1]Junichi Takada, [2]Rajani Dinavahi, [3]Akimitsu Miyauchi, [4]Etsuro Hamaya, [5]Toshiyasu Hirama, [6]Cesar Libanati, [7]Yoichi Nakamura, [8]Cassandra E Milmont, [9]Andreas Grauer [Full author list]Journal of Bone and Mineral Metabolism [missing]DOI: 10.1007/S00774-019-01057-1 [ORCID]
PubMed: 31707465 [ORCID]
2019-11-09Cesar Libanati (Q91116106; 7 items)
Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension[1]Akimitsu Miyauchi, [2]Rajani V Dinavahi, [3]Daria B Crittenden, [4]Wenjing Yang, [5]Judy C Maddox, [6]Etsuro Hamaya, [7]Yoichi Nakamura, [8]Cesar Libanati, [9]Andreas Grauer, [10]Junichiro Shimauchi [Full author list]Archives of Osteoporosis [missing]DOI: 10.1007/S11657-019-0608-Z [ORCID]
PubMed: 31168657 [ORCID]
placebo [missing]2019-06-05Cesar Libanati (Q91116106; 7 items)
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study[1]E Michael Lewiecki, [2]Rajani V Dinavahi, [3]Marise Lazaretti-Castro, [4]Peter R Ebeling, [5]Jonathan D Adachi, [6]Akimitsu Miyauchi, [7]Evelien Gielen, [8]Cassandra E Milmont, [9]Cesar Libanati, [10]Andreas Grauer [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.3622 [ORCID]
PubMed: 30508316 [ORCID]
2018-12-03Cesar Libanati (Q91116106; 7 items)
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome[1]Felicia Cosman, [2]Daria B Crittenden, [3]Serge Ferrari, [4]E Michael Lewiecki, [5]Juan Jaller-Raad, [6]Cristiano Zerbini, [7]Cassandra E Milmont, [8]Paul D Meisner, [9]Cesar Libanati, [10]Andreas Grauer [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.3439 [ORCID]
PubMed: 29750828 [ORCID]
2018-05-11Cesar Libanati (Q91116106; 7 items)
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.[1]Felicia Cosman, [2]Daria B Crittenden, [3]Serge Ferrari, [4]Aliya Khan, [5]Nancy E Lane, [6]Kurt Lippuner, [7]Toshio Matsumoto, [8]Cassandra E Milmont, [9]Cesar Libanati, [10]Andreas Grauer [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.3427 [ORCID]
PubMed: 29573473 [ORCID]
2018-03-24Cesar Libanati (Q91116106; 7 items)
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial[1]Bente L Langdahl, [2]Cesar Libanati, [3]Daria B Crittenden, [4]Michael A Bolognese, [5]Jacques P Brown, [6]Nadia S Daizadeh, [7]Eva Dokoupilova, [8]Klaus Engelke, [9]Joel S Finkelstein, [10]Harry K Genant, ... [Full author list]The Lancet [missing]DOI: 10.1016/S0140-6736(17)31613-6 [ORCID]
PubMed: 28755782 [ORCID]
osteoporosis [missing]; monoclonal antibody [missing]; phase III clinical trial [missing]2017-07-26Cesar Libanati (Q91116106; 7 items)
Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.[1]Hideaki Ishibashi, [2]Daria B Crittenden, [3]Akimitsu Miyauchi, [4]Cesar Libanati, [5]Judy Maddox, [6]Michelle Fan, [7]Li Chen, [8]Andreas Grauer [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2017.07.005 [ORCID]
PubMed: 28687496 [ORCID]
osteoporosis [missing]2017-07-04Cesar Libanati (Q91116106; 7 items)
Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass[1]Tony M Keaveny, [2]Daria B Crittenden, [3]Michael A Bolognese, [4]Harry K Genant, [5]Klaus Engelke, [6]Beatriz Oliveri, [7]Jacques P Brown, [8]Bente L Langdahl, [9]Chris Yan, [10]Andreas Grauer, [11]Cesar Libanati [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.3176 [ORCID]
PubMed: 28543940 [ORCID]
2017-06-26Cesar Libanati (Q91116106; 7 items)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis[1]Felicia Cosman, [2]Daria B Crittenden, [3]Jonathan D Adachi, [4]Neil Binkley, [5]Edward Czerwinski, [6]Serge Ferrari, [7]Lorenz C Hofbauer, [8]Edith Lau, [9]E Michael Lewiecki, [10]Akimitsu Miyauchi, [11]Cristiano A F Zerbini, [12]Cassandra E Milmont, [13]Li Chen, [14]Judy Maddox, [15]Paul D Meisner, [16]Cesar Libanati, [17]Andreas Grauer [Full author list]The New England Journal of Medicine [missing]DOI: 10.1056/NEJMOA1607948 [ORCID]
PubMed: 27641143 [ORCID]
osteoporosis [missing]2016-10-20Cesar Libanati (Q91116106; 7 items)
Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass[1]Harry K Genant, [2]Klaus Engelke, [3]Michael A Bolognese, [4]Carlos Mautalen, [5]Jacques P Brown, [6]Chris Recknor, [7]Stefan Goemaere, [8]Thomas Fuerst, [9]Yu-Ching Yang, [10]Andreas Grauer, [11]Cesar Libanati [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2932 [ORCID]
PubMed: 27487526 [ORCID]
2016-08-03Cesar Libanati (Q91116106; 7 items)
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis.[1]Roger Zebaze, [2]Cesar Libanati, [3]Michael R McClung, [4]José R Zanchetta, [5]David L Kendler, [6]Arne Høiseth, [7]Andrea Wang, [8]Ali Ghasem-Zadeh, [9]Ego Seeman [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2855 [ORCID]
PubMed: 27082709 [ORCID]
osteoporosis [missing]2016-04-15Cesar Libanati (Q91116106; 7 items)
Response to: Comment on: "Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis"[1]Kenneth Es Poole, [2]Graham M Treece, [3]Andrew H Gee, [4]Jacques P Brown, [5]Michael R McClung, [6]Andrea Wang, [7]Cesar Libanati [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2569 [ORCID]
PubMed: 26174164 [ORCID]
osteoporosis [missing]2015-07-14Cesar Libanati (Q91116106; 7 items)
Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology[1]Philippe Zysset, [2]Dieter H. Pahr, [3]Klaus Engelke, [4]Harry K Genant, [5]Michael R McClung, [6]David L Kendler, [7]Christopher Recknor, [8]Michael Kinzl, [9]Jakob Schwiedrzik, [10]Oleg Museyko, [11]Andrea Wang, [12]Cesar Libanati [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2015.06.025 [ORCID]
PubMed: 26141837 [ORCID]
2015-07-02
Journal of Bone and Mineral Research: Volume 30, Issue 5, May 2015, Frontmatter page ii[1]Michael S Ominsky, [2]Cesar Libanati, [3]Qing-Tian Niu, [4]Rogely W Boyce, [5]Paul J Kostenuik, [6]Rachel B Wagman, [7]Roland Baron, [8]David W Dempster [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2543 [ORCID]
PubMed: 25959690 [ORCID]
2015-05-10Cesar Libanati (Q91116106; 7 items)
Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis[1]Kenneth E S Poole, [2]Graham M Treece, [3]Andrew H Gee, [4]Jacques P Brown, [5]Michael McClung, [6]Andrea Wang, [7]Cesar Libanati [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2325 [ORCID]
PubMed: 25088963 [ORCID]
osteoporosis [missing]2015-01-01Cesar Libanati (Q91116106; 7 items)
Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab[1]Tony M Keaveny, [2]Michael McClung, [3]Harry K Genant, [4]Jose R Zanchetta, [5]David Kendler, [6]Jacques P Brown, [7]Stefan Goemaere, [8]Chris Recknor, [9]Maria Luisa Brandi, [10]Richard Eastell, [11]David L Kopperdahl, [12]Klaus Engelke, [13]Thomas Fuerst, [14]Hoi-Shen Radcliffe, [15]Cesar Libanati [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2024 [ORCID]
PubMed: 23794225 [ORCID]
osteoporosis [missing]2014-01-01Cesar Libanati (Q91116106; 7 items)
Romosozumab in postmenopausal women with low bone mineral density[1]Michael McClung, [2]Andreas Grauer, [3]Steven Boonen, [4]Michael A Bolognese, [5]Jacques P. Brown, [6]Adolfo Díez-Pérez, [7]Bente L Langdahl, [8]Jean-Yves Reginster, [9]Jose R Zanchetta, [10]Scott M Wasserman, [11]Leonid Katz, [12]Judy Maddox, [13]Yu-Ching Yang, [14]Cesar Libanati, [15]Henry G Bone [Full author list]The New England Journal of Medicine [missing]DOI: 10.1056/NEJMOA1305224 [ORCID]
PubMed: 24382002 [ORCID]
2014-01-01Cesar Libanati (Q91116106; 7 items)
Differing effects of denosumab and alendronate on cortical and trabecular bone[1]Roger M Zebaze, [2]Cesar Libanati, [3]Matthew Austin, [4]Ali Ghasem-Zadeh, [5]David A Hanley, [6]Jose R Zanchetta, [7]Thierry Thomas, [8]Stephanie Boutroy, [9]Cesar E Bogado, [10]John P Bilezikian, [11]Ego Seeman [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2013.11.016 [ORCID]
PubMed: 24275677 [ORCID]
2013-11-22
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab[1]Harry K Genant, [2]Cesar Libanati, [3]Klaus Engelke, [4]Jose R Zanchetta, [5]Arne Høiseth, [6]Chui Kin Yuen, [7]Sigtas Stonkus, [8]Michael A Bolognese, [9]Edward Franek, [10]Thomas Fuerst, [11]Hoi-Shen Radcliffe, [12]Michael McClung [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2013.07.011 [ORCID]
PubMed: 23871852 [ORCID]
osteoporosis [missing]2013-07-17
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.[1]James A Simon, [2]Christopher Recknor, [3]Alfred H Moffett, [4]Jonathan D Adachi, [5]Edward Franek, [6]E Michael Lewiecki, [7]Michael McClung, [8]Carlos A Mautalen, [9]Sergio Ragi-Eis, [10]Geoffrey C. Nicholson, [11]Christian Muschitz, [12]Ranuccio Nuti, [13]Ove Törring, [14]Andrea Wang, [15]Cesar Libanati [Full author list]Menopause [missing]DOI: 10.1097/GME.0B013E318267F909 [ORCID]
PubMed: 23010883 [ORCID]
osteoporosis [missing]2013-02-01Cesar Libanati (Q91116106; 7 items)
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial[1]Silvano Adami, [2]Cesar Libanati, [3]Steven Boonen, [4]Steven R Cummings, [5]Pei-Ran Ho, [6]Andrea Wang, [7]Ethel Siris, [8]Joseph Lane, [9]FREEDOM Fracture-Healing Writing Group, [10]Jonathan D Adachi, [11]Mohit Bhandari, [12]Luiz de Gregorio, [13]Nigel Gilchrist, [14]George Lyritis, [15]Gerd Möller, [16]Santiago Palacios, [17]Karel Pavelka, [18]Resch Heinrich, [19]Christian Roux, [20]Daniel Uebelhart [Full author list]Journal of Bone and Joint Surgery [missing]DOI: 10.2106/JBJS.K.00774 [ORCID]
PubMed: 23097066 [ORCID]
2012-12-01Cesar Libanati (Q91116106; 7 items)
Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis[1]Michael McClung, [2]Jose R Zanchetta, [3]Arne Høiseth, [4]David Kendler, [5]Chui Kin Yuen, [6]Jacques P Brown, [7]Sigitas Stonkus, [8]Stefan Goemaere, [9]Chris Recknor, [10]Grattan C Woodson, [11]Michael A Bolognese, [12]Edward Franek, [13]Maria Luisa Brandi, [14]Andrea Wang, [15]Cesar Libanati [Full author list]Journal of Clinical Densitometry [missing]DOI: 10.1016/J.JOCD.2012.02.014 [ORCID]
PubMed: 22572531 [ORCID]
computed tomography [missing]; osteoporosis [missing]2012-05-08Cesar Libanati (Q91116106; 7 items)
Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study[1]Michael A Bolognese, [2]Christence Stubbe Teglbjærg, [3]Jose R Zanchetta, [4]Kurt Lippuner, [5]Michael McClung, [6]Maria Luisa Brandi, [7]Arne Høiseth, [8]Péter Lakatos, [9]Alfred H Moffett, [10]Roman S Lorenc, [11]Andrea Wang, [12]Cesar Libanati [Full author list]Journal of Clinical Densitometry [missing]DOI: 10.1016/J.JOCD.2012.02.006 [ORCID]
PubMed: 22521543 [ORCID]
2012-04-20Cesar Libanati (Q91116106; 7 items)
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures[1]Matthew Austin, [2]Yu-Ching Yang, [3]Eric Vittinghoff, [4]Silvano Adami, [5]Steven Boonen, [6]Douglas C Bauer, [7]Gerolamo Bianchi, [8]Michael A Bolognese, [9]Claus Christiansen, [10]Richard Eastell, ..., [18]Jose Zanchetta, [19]Cristiano A F Zerbini, [20]Cesar Libanati, [21]Steven R Cummings, [22]FREEDOM Trial [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.1472 [ORCID]
PubMed: 22095631 [ORCID]
2012-03-01Cesar Libanati (Q91116106; 7 items)
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis[1]Richard Eastell, [2]Claus Christiansen, [3]Andreas Grauer, [4]Stepan Kutilek, [5]Cesar Libanati, [6]Michael McClung, [7]Ian Reid, [8]Heinrich Resch, [9]Ethel Siris, [10]Daniel Uebelhart, [11]Andrea Wang, [12]Georges Weryha, [13]Steve R Cummings [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.251 [ORCID]
PubMed: 20839290 [ORCID]
osteoporosis [missing]; postmenopausal osteoporosis [missing]2011-03-01Cesar Libanati (Q91116106; 7 items)
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate[1]Ego Seeman, [2]Pierre D. Delmas, [3]David A Hanley, [4]Deborah Sellmeyer, [5]Angela M. Cheung, [6]Elizabeth Shane, [7]Ann Kearns, [8]Thierry Thomas, [9]Steven K Boyd, [10]Stephanie Boutroy, [11]Cesar Bogado, [12]Sharmila Majumdar, [13]Michelle Fan, [14]Cesar Libanati, [15]Jose Zanchetta [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.81 [ORCID]
PubMed: 20222106 [ORCID]
2010-08-01
Denosumab for prevention of fractures in postmenopausal women with osteoporosis[1]Steven R Cummings, [2]Javier San Martin, [3]Michael McClung, [4]Ethel S Siris, [5]Richard Eastell, [6]Ian Reid, [7]Pierre D. Delmas, [8]Holly B Zoog, [9]Matt Austin, [10]Andrea Wang, [11]Stepan Kutilek, [12]Silvano Adami, [13]Jose Zanchetta, [14]Cesar Libanati, [15]Suresh Siddhanti, [16]Claus Christiansen [Full author list]The New England Journal of Medicine [missing]DOI: 10.1056/NEJMOA0809493 [ORCID]
PubMed: 19671655 [ORCID]
bone fracture [missing]; osteoporosis [missing]2009-08-20Cesar Libanati (Q91116106; 7 items)
Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray absorptiometry (DXA).[1]Klaus Engelke, [2]Cesar Libanati, [3]Yu Liu, [4]Huei Wang, [5]Matt Austin, [6]Tom Fuerst, [7]Bernd Stampa, [8]Wolfram Timm, [9]Harry K Genant [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2009.03.669 [ORCID]
PubMed: 19345291 [ORCID]
computed tomography [missing]2009-04-02
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial[1]Jacques P Brown, [2]Richard L Prince, [3]Chad Deal, [4]Robert R Recker, [5]Douglas P Kiel, [6]Luiz H de Gregorio, [7]Peyman Hadji, [8]Lorenz C Hofbauer, [9]Jose M Alvaro-Gracia, [10]Huei Wang, [11]Matthew Austin, [12]Rachel B Wagman, [13]Richard Newmark, [14]Cesar Libanati, [15]Javier San Martin, [16]Henry G Bone [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1359/JBMR.0809010 [ORCID]
PubMed: 18767928 [ORCID]
phase III clinical trial [missing]2009-01-01Cesar Libanati (Q91116106; 7 items)
Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate[1]Thomas J Beck, [2]E Michael Lewiecki, [3]Paul D Miller, [4]Dieter Felsenberg, [5]Yu Liu, [6]Beiying Ding, [7]Cesar Libanati [Full author list]Journal of Clinical Densitometry [missing]DOI: 10.1016/J.JOCD.2008.04.001 [ORCID]
PubMed: 18495508 [ORCID]
2008-05-20

Misc

Matched potential author: Cesar Libanati - author of 7 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data[1]Sara Khalid, [2]Carlen Reyes, [3]Martin Ernst, [4]Antonella Delmestri, [5]Emese Toth, [6]Cesar Libanati, [7]Bo Abrahamsen, [8]Daniel Prieto-Alhambra [Full author list]Osteoporosis International [missing]DOI: 10.1007/S00198-021-06077-0 [ORCID]
PubMed: 34392386 [ORCID]
2021-08-15
Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis[1]Christian Graeff, [2]Graeme M Campbell, [3]Jaime Peña, [4]Jan Borggrefe, [5]Desmond Padhi, [6]Allegra Kaufman, [7]Sung Chang, [8]Cesar Libanati, [9]Claus-Christian Glüer [Full author list]Bone [missing]DOI: 10.1016/J.BONE.2015.07.036 [ORCID]
PubMed: 26232375 [ORCID]
tomography [missing]2015-07-29
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab[1]Michael S Ominsky, [2]Cesar Libanati, [3]Qing-Tian Niu, [4]Rogely W Boyce, [5]Paul J Kostenuik, [6]Rachel B Wagman, [7]Roland Baron, [8]David W Dempster [Full author list]Journal of Bone and Mineral Research [missing]DOI: 10.1002/JBMR.2480 [ORCID]
PubMed: 25684625 [ORCID]
2015-07-01Cesar Libanati (Q91116106; 7 items)
Time course of bone mineral density changes with denosumab compared with other drugs in postmenopausal osteoporosis: a dose-response-based meta-analysis[1]Jaap W Mandema, [2]Jenny Zheng, [3]Cesar Libanati, [4]Juan Jose Perez Ruixo [Full author list]The Journal of Clinical Endocrinology and Metabolism [missing]DOI: 10.1210/JC.2013-3795 [ORCID]
PubMed: 24915115 [ORCID]
osteoporosis [missing]; postmenopausal osteoporosis [missing]2014-06-10
Comparison of body composition by bioelectrical impedance and dual-energy x-ray absorptiometry in overweight/obese postmenopausal women.[1]Dina H Fakhrawi, [2]Lawrence Beeson, [3]Cesar Libanati, [4]Daniel Feleke, [5]Hannah Kim, [6]Alfred Quansah, [7]Allan Darnell, [8]Carol J Lammi-Keefe, [9]Zaida Cordero-MacIntyre [Full author list]Journal of Clinical Densitometry [missing]DOI: 10.1016/J.JOCD.2009.01.004 [ORCID]
PubMed: 19285894 [ORCID]
obesity [missing]2009-03-13
Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal[1]Jon E Wergedal, [2]Katarina Veskovic, [3]Minea Hellan, [4]Christine Nyght, [5]Wendy Balemans, [6]Cesar Libanati, [7]Filip M Vanhoenacker, [8]Johan Tan, [9]David J Baylink, [10]Wim Van Hul [Full author list]The Journal of Clinical Endocrinology and Metabolism [missing]DOI: 10.1210/JC.2003-030201 [ORCID]
PubMed: 14671168 [ORCID]
moment of inertia [missing]; genetic disease [missing]2003-12-01
Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links[1]Apurva K. Srivastava, [2]Cesar Libanati, [3]Walter Oberrauch, [4]Joerg Leenings, [5]Maria Greenwald, [6]David J. Baylink [Full author list]Journal of Bone and Mineral Metabolism [missing]DOI: 10.1007/S007740300022 [ORCID]
PubMed: 12720047 [ORCID]
endocrinology [missing]; diagnostic reagent kit [missing]; Orthopedics and sports medicine [missing]2003-01-01

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Cesar Libanatiresearcher (ORCID 0000-0003-1427-7839)7ORCID: 0000-0003-1427-7839
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Cesar Libanati | Author has ORCID ID:
Check VIAF for Cesar Libanati | Author has VIAF ID:
Check ResearchGate for Cesar Libanati | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers


Feedback
Source and documentation (at github)
Wikidata page